Ryan Robinson (CEO)

Ryan Robinson is a visionary who builds quantum technology in an effort to change the world for the better.

Born in Miami, Ryan began taking college classes at Harvard when he was 16. He also competed in DECA, the world's largest business competition and scored in the highest percentile (99%) for both economics and marketing management. After his acceptance into MIT, he began researching dark matter at the age of 18. After studying under Professor Eric Lander, Ryan created Conduit, a company dedicated to creating products that will help solve the most important challenges of today. Advised by Professor Seth Lloyd, Ryan created his own major called quantum engineering. Ryan graduated from MIT with three majors in total: mechatronics, international humanities, and quantum engineering. During his time at MIT, he also published a paper about gender bias in the workplace.

When he was 22, Ryan was featured in Forbes for his work at Conduit. He lectured at MIT about quantum computing and cryptocurrency. Also at MIT, Ryan premiered Conduit's computational innovations, which sped up certain supercomputing tasks by a factor of 100x. These innovations were implemented by Ricky Williams, lead software engineer at Conduit. After Ryan lectured on Conduit's achievements in high-performance computing, he was compared to "Steve Jobs in his prime" by MIT professor Jeremy Kepner.

During 2020, Ryan's company began working with the White House's COVID-19 High-Performance Computing Consortium to help better understand SARS-CoV-2 and to search for treatments for COVID-19 as well as other coronaviral diseases. Ryan and his team members represent the youngest people who are part of the White House's COVID-19 High-Performance Computing Consortium. 

Ryan has led the business side of Conduit's effort to develop nanoSPLASH, a home diagnostic for COVID-19 and other infectious diseases. NanoSPLASH has the potential to save millions of lives by preventing the spread of disease.

Since Ryan believes that the arts and sciences go hand in hand, he has kept in touch with his artistic side as well. Ryan is a published poet and jazz saxophonist.

Ryan has been featured in MIT News, American Inno, Boston Business Journal, Information Age, CNN, Moguldom, Forbes, and the World News.


Logan Thrasher Collins (CTO)

Logan Thrasher Collins is an innovator and futurist who builds nanotechnology in an effort to change the world for the better.

When Logan was 16 years old, he invented a de novo antimicrobial peptide called OpaL as a new way of combatting antibiotic resistant infections. He subsequently developed a bacterial conjugation delivery system for the gene encoding this peptide. For this synthetic biology research, Logan was a three-time finalist at the Intel International Science and Engineering Fair (ISEF), the world’s largest scientific research competition for high school students. During 2014, he won 1st place and best of category in microbiology at ISEF. He also won a top award called the Dudley R. Herschbach SIYSS Award, which gave him a trip to take part in the Nobel Prize ceremonies in Stockholm, Sweden. As part of his honors at ISEF, a minor planet was officially named after Logan. His research was also recognized at the International BioGENEius Challenge and at the American Society for Microbiology General Meeting. When Logan was 17, he gave a TEDx talk on his research. Logan started taking college-level classes when he was 14 years old.

During college, Logan continued to pursue scientific research. He published his synthetic biology research in the scientific journal ACS Biochemistry and he published a prospects paper on insect brain simulation in the scientific journal Biological Cybernetics. Funded by the prestigious Beckman scholarship, Logan also developed a nanotechnology-based contrast agent as a way of helping to map the structure of the brain.

Logan joined Conduit shortly after he graduated from college. At Conduit, he wrote a proposal to the White House’s COVID-19 High-Performance Computing Consortium. After his proposal was accepted, he led a team of software engineers and computational biologists through the process of implementing supercomputer simulations of part of the SARS-CoV-2 lifecycle. Logan and his team used Frontera, the 9th most powerful supercomputer in the world. Logan and his team uncovered new insights about the biology of SARS-CoV-2. They are now finalizing the quantitative data analysis of the simulations. Logan plans to publish the results in a scientific journal.

Logan has led the scientific side of Conduit’s effort to develop nanoSPLASH, which will serve as a home diagnostic test for COVID-19 and other infectious diseases. Logan invented the original nanoSPLASH design and is now collaborating with a company called Avomeen to develop nanoSPLASH into a reality. NanoSPLASH could potentially save millions of lives by curbing the spread of infection.

Logan is also a PhD candidate in biomedical engineering and is using synthetic biology and to develop new types of adenoviral gene therapy.

Because Logan believes that the arts and sciences are intrinsically linked, he has kept in touch with his artistic side as well. He writes science fiction and sci-fi poetry. Through this pursuit, he has had several fiction and poetry pieces published in online magazines. One of his poems, Neuraweb, was nominated for the Rhysling award and the Pushcart award.

Logan is actively working towards making the future the best that it can be.